Novartis appoints new CFO
This article was originally published in Scrip
Executive Summary
Novartis has appointed Jonathan Symonds deputy chief financial officer and CFO designate, replacing current CFO Raymund Breu, who will retire in March next year. Mr Symonds most recently served as managing director of investment banking at Goldman Sachs, and prior to that worked as CFO at AstraZeneca and as a partner at KPMG.